288 related articles for article (PubMed ID: 30115986)
21. HIV transmitted drug resistance in adult and pediatric populations in Panama.
Castillo J; Arteaga G; Mendoza Y; Martínez AA; Samaniego R; Estripeaut D; Page KR; Smith RE; Sosa N; Pascale JM
Rev Panam Salud Publica; 2011 Dec; 30(6):649-56. PubMed ID: 22358417
[TBL] [Abstract][Full Text] [Related]
22. Treatment-naive individuals are the major source of transmitted HIV-1 drug resistance in men who have sex with men in the Swiss HIV Cohort Study.
Drescher SM; von Wyl V; Yang WL; Böni J; Yerly S; Shah C; Aubert V; Klimkait T; Taffé P; Furrer H; Battegay M; Ambrosioni J; Cavassini M; Bernasconi E; Vernazza PL; Ledergerber B; Günthard HF; Kouyos RD;
Clin Infect Dis; 2014 Jan; 58(2):285-94. PubMed ID: 24145874
[TBL] [Abstract][Full Text] [Related]
23. [Transmitted drug resistance among HIV infected men who have sex with men in Tianjin, 2014-2017].
Zheng MN; Ning TL; Zhou N; Zhao X; Li L; Zhu JJ; Cheng SH
Zhonghua Liu Xing Bing Xue Za Zhi; 2018 May; 39(5):619-624. PubMed ID: 29860805
[No Abstract] [Full Text] [Related]
24. Transmitted Drug Resistance Mutations in Antiretroviral-Naïve Injection Drug Users with Chronic HIV-1 Infection in Iran.
Memarnejadian A; Menbari S; Mansouri SA; Sadeghi L; Vahabpour R; Aghasadeghi MR; Mostafavi E; Abdi M
PLoS One; 2015; 10(5):e0126955. PubMed ID: 25962088
[TBL] [Abstract][Full Text] [Related]
25. Prevalence and patterns of HIV transmitted drug resistance in Guatemala.
Avila-Ríos S; Mejía-Villatoro CR; García-Morales C; Soto-Nava M; Escobar I; Mendizabal R; Girón A; García L; Reyes-Terán G
Rev Panam Salud Publica; 2011 Dec; 30(6):641-8. PubMed ID: 22358416
[TBL] [Abstract][Full Text] [Related]
26. Transmitted HIV drug resistance among individuals with newly diagnosed HIV infection: a multicenter observational study.
Ye J; Hao M; Xing H; Zhang F; Wu H; Lv W; Jiang T; Wang Y; Wang J; Feng Y; Xin R; Zeng J; Zhao S; Hao Y; Chen J; Ruan Y; Li X; Shao Y; Lu H
AIDS; 2020 Mar; 34(4):609-619. PubMed ID: 31895143
[TBL] [Abstract][Full Text] [Related]
27. Increasing Prevalence of HIV-1 Transmitted Drug Resistance in Portugal: Implications for First Line Treatment Recommendations.
Pingarilho M; Pimentel V; Diogo I; Fernandes S; Miranda M; Pineda-Pena A; Libin P; Theys K; Martins MRO; Vandamme AM; Camacho R; Gomes P; Abecasis A
Viruses; 2020 Oct; 12(11):. PubMed ID: 33143301
[TBL] [Abstract][Full Text] [Related]
28. Transmitted drug resistance to Tenofovir/Emtricitabine among persons with newly diagnosed HIV infection in Shenyang city, Northeast China from 2016 to 2018.
Wang Z; Zhao B; An M; Song W; Dong X; Li X; Wang L; Wang L; Tian W; Ding H; Han X
BMC Infect Dis; 2021 Jul; 21(1):668. PubMed ID: 34243716
[TBL] [Abstract][Full Text] [Related]
29. Transmitted drug resistance in newly diagnosed and treatment-naïve HIV type 1-infected patients in Hungary.
Áy É; Müller V; Mezei M; Pocskay Á; Koroknai A; Müller D; Győri Z; Marschalkó M; Tóth B; Kárpáti S; Lakatos B; Szlávik J; Takács M; Minárovits J
J Glob Antimicrob Resist; 2020 Mar; 20():124-130. PubMed ID: 31330377
[TBL] [Abstract][Full Text] [Related]
30. Evolution of transmitted HIV-1 drug resistance and viral subtypes circulation in Italy from 2006 to 2016.
Rossetti B; Di Giambenedetto S; Torti C; Postorino MC; Punzi G; Saladini F; Gennari W; Borghi V; Monno L; Pignataro AR; Polilli E; Colafigli M; Poggi A; Tini S; Zazzi M; De Luca A;
HIV Med; 2018 Oct; 19(9):619-628. PubMed ID: 29932313
[TBL] [Abstract][Full Text] [Related]
31. HIV-1 transmitted drug resistance in Slovenia and its impact on predicted treatment effectiveness: 2011-2016 update.
Lunar MM; Židovec Lepej S; Tomažič J; Vovko TD; Pečavar B; Turel G; Maver M; Poljak M
PLoS One; 2018; 13(4):e0196670. PubMed ID: 29698470
[TBL] [Abstract][Full Text] [Related]
32. HIV-1 genetic diversity and transmitted drug resistance frequency among Iranian treatment-naive, sexually infected individuals.
Vahabpour R; Bokharaei-Salim F; Kalantari S; Garshasbi S; Monavari SH; Esghaei M; Memarnejadian A; Fakhim A; Keyvani H
Arch Virol; 2017 Jun; 162(6):1477-1485. PubMed ID: 28181034
[TBL] [Abstract][Full Text] [Related]
33. Epidemiological Surveillance of HIV-1 Transmitted Drug Resistance in Spain in 2004-2012: Relevance of Transmission Clusters in the Propagation of Resistance Mutations.
Vega Y; Delgado E; Fernández-García A; Cuevas MT; Thomson MM; Montero V; Sánchez M; Sánchez AM; Pérez-Álvarez L;
PLoS One; 2015; 10(5):e0125699. PubMed ID: 26010948
[TBL] [Abstract][Full Text] [Related]
34. Prevalence of transmitted drug resistance among HIV-1 treatment-naive patients in Beijing.
Song YX; Xin RL; Li ZC; Yu HW; Lun WH; Ye J; Liu A; Li AX; Li JW; Ye JZ; Hao MQ; Lu HY; Sun LJ
Epidemiol Infect; 2018 Feb; 146(3):339-344. PubMed ID: 29345606
[TBL] [Abstract][Full Text] [Related]
35. The prevalence of drug resistance mutations among treatment-naive HIV-infected individuals in Beijing, China.
Ye JR; Lu HY; Wang WS; Guo L; Xin RL; Yu SQ; Wu TC; Zeng Y; He X
AIDS Res Hum Retroviruses; 2012 Apr; 28(4):418-23. PubMed ID: 21830915
[TBL] [Abstract][Full Text] [Related]
36. Molecular and epidemiological characterization of HIV-1 infection networks involving transmitted drug resistance mutations in Northern Greece.
Skoura L; Metallidis S; Buckton AJ; Mbisa JL; Pilalas D; Papadimitriou E; Papoutsi A; Haidich AB; Chrysanthidis T; Tsachouridou O; Antoniadou ZA; Kollaras P; Nikolaidis P; Malisiovas N
J Antimicrob Chemother; 2011 Dec; 66(12):2831-7. PubMed ID: 21933785
[TBL] [Abstract][Full Text] [Related]
37. Characterization of HIV-1 subtypes and transmitted drug resistance among treatment-naive HIV-infected individuals in Zhejiang, China, 2014-2017.
Xu Y; Peng X; Peng X; Ji S; Chen B; Wang L; Lu X; Xie T; Sun T; Wang H; Wu N
Arch Virol; 2018 Aug; 163(8):2233-2237. PubMed ID: 29637428
[TBL] [Abstract][Full Text] [Related]
38. Prevalence of transmitted antiretroviral resistance and distribution of HIV-1 subtypes among patients with recent infection in Catalonia (Spain) between 2003 and 2005.
Romero A; Sued O; Puig T; Esteve A; Pumarola T; Casabona J; González V; Matas L; Tural C; Rodrigo I; Margall N; Domingo P; Casanova A; Ferrer E; Caballero E; Ribera E; Farré J; Puig T; Amengual MJ; Navarro G; Prat JM; Masabeu A; Simó JM; Villaverde CA; Barrufet P; Sauca MG; Ortin X; Ortí A; Navarro R; Euras JM; Vilaró J; Villà MC; Montull S; Vilanova C; Pujol F; Díaz O; Miró JM;
Enferm Infecc Microbiol Clin; 2011; 29(7):482-9. PubMed ID: 21543135
[TBL] [Abstract][Full Text] [Related]
39. Genetic Diversity and Drug Resistance Among Antiretroviral Treatment-Failed Individuals from 2010 to 2012 in Honghe, China.
Yang C; Yang S; Li J; Yang B; Liu J; Li H; Bian Z
AIDS Res Hum Retroviruses; 2015 Aug; 31(8):822-9. PubMed ID: 25919896
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of transmitted drug resistance among ART-naïve HIV-infected individuals, Beijing, 2015-2018.
Li R; Song C; Chen D; Li C; Hao Y; Zeng H; Han J; Zhao H
J Glob Antimicrob Resist; 2022 Mar; 28():241-248. PubMed ID: 35092830
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
